New program from the veteran hemp marketing agency takes aim at the industry's biggest blind spot — specialized...





New program from the veteran hemp marketing agency takes aim at the industry's biggest blind spot — specialized...
Disclaimer: The views expressed in this contributed article are those of the author and do not necessarily reflect the...
Why Co‑Development Is on Pharma’s Radar NowThree Regulatory Worlds, One Cannabinoid Therapeutics ProgramDeal...
Table of ContentsA different kind of Brazil cannabis compliance modelWhy Milgrows is central to the strategyRacing an...
Disclaimer: This article is for informational purposes only and does not constitute legal or regulatory advice....
Table of ContentsAI Supported Tech In the Grow: From Gut Feel to Data‑FirstWhat this means for operators:Compliance,...
By Jonathan Ballard, Vice President, LeafyPack Jonathan Ballard is Vice President of LeafyPack, bringing deep cannabis...
A new push toward Schedule IIIResearch, medical access, and patientsMoney, taxes, and industry shakeupHemp,...
What 280E Relief Really ChangesFrom Fire Drills To Real Capex PlansWhy “Infrastructure” Deserves Front‑Page...
Impact of the Hemp Ban: Accelerating Asset DispositionCapitalizing on Surplus: Tips for Licensed Cannabis BuyersBroker...
Safety Standards for Manufacturers, Extractors, Cultivators, Dispensaries, & Distributors Now Available St. Louis,...
Safety Standards for Dispensaries and Cannabinoid Product Warehouses and Distributors Now Available for Review St....
Written by Sarah Gullickson, The Cannabis Business Advisors Table of ContentsWhat Worked What Didn’t Lessons and...
Hot take: Metrc isn’t broken — it’s working exactly as intended. An opinion piece by Luna Stower, into how legalization is a cover for commercialize and over-regulation. This is how cannabis “legalization” became a tool for corporate consolidation, not freedom.
By Yasha Shamayeli, Director of Marketing, LeafyPack Packaging Compliance ChallengesOvercoming Compliance Issues with...
Austin Ownbey is an antitrust regulatory partner in Akerman's Corporate Practice where his work includes representing...
Lunar New Year 2025 is approaching and the cannabis industry faces a pressing but often overlooked challenge—its reliance on Chinese manufacturing.
Marijuana lobbyists push to suppress hemp-derived cannabinoids under “public safety,” yet data shows risks are similar. Is this about safety or protecting profits?
Why Does it Even Matter? Compliance is Just the Tip of the IcebergWhat Are Terpenes?What Are Flavors?Flavors vs....
What is TAC?Why Should Consumers Care About TAC?TAC TransparencyTHCaTHCCBCCBDCBNTHCV When shopping for cannabis...
Regulators are progressing with Pillar 2 German cannabis legalization, including a pilot for adult-use via social clubs and dispensaries, yet uncertainties remain.